Global increase in circRNA levels in myotonic dystrophy
Authors:
- Karol CzubakKCKarol Czubak
- Katarzyna TaylorKTKatarzyna Taylor
- Agnieszka PiaseckaAPAgnieszka Piasecka
- Krzysztof SobczakKSKrzysztof Sobczak
- Katarzyna KozlowskaKKKatarzyna Kozlowska
- Anna PhilipsAnna Philips
- Saam SedehizadehSSSaam Sedehizadeh
- John David BrookJBJohn David Brook
- Marzena WojciechowskaMWMarzena Wojciechowska
- Piotr KozlowskiPiotr Kozlowski
Preprint
Abstract
Splicing aberrations induced as a consequence of the sequestration of MBNL splicing factors on the DMPK transcript, which contains expanded CUG repeats, present a major pathomechanism of myotonic dystrophy type 1 (DM1). As MBNLs may also be important factors involved in the biogenesis of circular RNAs (circRNAs), we hypothesized that the level of circRNAs would be decreased in DM1. To test this hypothesis, we selected twenty well-validated circRNAs and analyzed their levels in several experimental systems (e.g., cell lines, DM muscle tissues, and a mouse model of DM1) using droplet digital PCR assays. We also explored the global level of circRNAs using two RNA-Seq datasets of DM1 muscle samples. Contrary to our original hypothesis, our results consistently showed a global increase in circRNA levels in DM1 and we identified numerous circRNAs that were increased in DM1. We also identified many genes (including muscle-specific genes) giving rise to numerous (>10) circRNAs. Thus, this study is the first to show an increase in global circRNA levels in DM1. We also provided preliminary results showing the association of circRNA level with muscle weakness and alternative splicing changes that are biomarkers of DM1 severity. Author Summary: Recently, a great deal of interest has been focused on a new class of RNA molecules called circular RNAs (circRNAs). To date, thousands of circRNAs have been found in different human cells/tissues. Although the function of circRNAs remains mostly unknown, circRNAs have emerged as an important component of the RNA-RNA and RNA-protein interactome. Thus, intensive efforts are being made to fully understand the biology and function of circRNAs, especially their role in human diseases. As an important role in the biogenesis of circRNA may be played by MBNL splicing factors, in this study we used DM1 (to a lesser extent, DM2) as a natural model in which the level of MBNLs is decreased. In contrast to the expected effect, our results consistently showed a global increase in circRNA levels in DM1. As a consequence, whole genome transcriptome analysis revealed dozens of circRNAs with significantly altered (mostly increased) levels in DM1. Furthermore, we observed that the circRNA levels were in many cases strongly associated with DM1 severity.Keywords
All Related Versions
- Published version: Frontiers in Genetics, 10, 649.
This publication has 53 references indexed in Scilit:
- Cell-Type Specific Features of Circular RNA ExpressionPLOS Genetics, 2013
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNAThe EMBO Journal, 2011
- Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophyNature Structural & Molecular Biology, 2010
- MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicingNucleic Acids Research, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- Muscleblind proteins regulate alternative splicingThe EMBO Journal, 2004
- Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophyThe EMBO Journal, 2000